ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Arvaya Healthcare Limited held its 41st Annual General Meeting on 21st September 2026, where members adopted financial statements and approved material related party transactions.
Arvaya Healthcare has incorporated a wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, for an investment of ₹0.80 Crore. This entity will provide insurance broking services.
Arvaya Healthcare Limited has dispatched web links to shareholders for accessing the Notice of its 41st Annual General Meeting and the Annual Report.
Arvaya Healthcare filed its 41st Annual Report for FY 2025-26, including the notice for the Annual General Meeting scheduled on 21 September 2026.
Arvaya Healthcare Limited issued a Notice of its 41st Annual General Meeting to be held on 21 September 2026 via video conferencing. The agenda includes approval for material related party transactions.
Arvaya Healthcare Limited approved the acquisition of a Copyright and Intellectual Property portfolio from Defib Institute of Health Solutions LLP for a consideration of ₹10 Crores.
Arvaya Healthcare Limited scheduled a board meeting for August 26, 2026, to discuss a related party transaction regarding the acquisition of a business undertaking.
Arvaya Healthcare Limited submitted the voting results and the Scrutinizer's Report for its recent Postal Ballot. The company confirmed that all 6 resolutions were successfully passed.
Arvaya Healthcare Limited plans to incorporate a new wholly-owned subsidiary to operate in the insurance broking service sector. The company will hold 100% equity stake.
Arvaya Healthcare Limited has informed the exchange that the Statement of Deviation or Variation under Regulation 32 is not applicable for the quarter ended June 2026.
Arvaya Healthcare Ltd reported revenue from operations of ₹29.9 Cr and net profit of ₹0.5 Cr for Q1 FY27.
Arvaya Healthcare scheduled a Board Meeting for August 12, 2026, to consider financial results, AGM proceedings, and various appointments.
Arvaya Healthcare Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026. This submission complies with SEBI Regulation 31(1)(b) requirements.
Arvaya Healthcare Limited issued a Postal Ballot notice for shareholders to approve the acquisition of Sushodha Institute of Gastroenterology. Voting ends on August 13, 2026.
Arvaya Healthcare approved a Rs. 15.49 Crore preferential issue of 3,871,854 equity shares. The issue price is set at Rs. 40 per share for 47 investors.
Arvaya Healthcare will acquire Sushodha Institute of Gastroenterology for Rs.15.49 Crore via share swap. The 100% stake acquisition expands its specialized healthcare footprint in India.
Arvaya Healthcare approved the 100% acquisition of SIGPL for Rs. 15.49 Crore via share swap. The board also proposed a Rs. 210 Crore rights issue.
Bijoy Hans Ltd is now Arvaya Healthcare Limited, effective July 13, 2026. The BSE has updated its records and Scrip ID to ARVAYA.